Latest filing published 30 Dec 2021 for Neogenomics INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jennifer Balliet: trading record in brief
Jennifer Balliet is a declared insider of Neogenomics Inc (senior executive), with filings sourced from SEC (Form 4). Between 29 April 2016 and 30 December 2021, the trades on record add up to 46 filings.
Every open-market trade on record is a sale: 15 sales worth €4.5M. The rest of the record consists of 9 share grants and 20 option exercises.
Most recently, on 30 December 2021, the filings show a share grant in Neogenomics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer Balliet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,400 shares0Common StockSEC:0001077183-21-000274:0
- 758 shares0Common StockSEC:0001077183-21-000185:0
2 of 2 declarations
